(Q37888655)

24 August 2017

1 reference

title

Drug-induced acneiform eruption (English)

1 reference

24 August 2017

Aurélie Du-Thanh

1

1 reference

24 August 2017

Nicolas Kluger

series ordinal

2

1 reference

24 August 2017

Houdna Bensalleh

series ordinal

3

1 reference

24 August 2017

Bernard Guillot

series ordinal

4

1 reference

24 August 2017

publication date

1 August 2011

1 reference

American Journal of Clinical Dermatology

24 August 2017

published in

1 reference

24 August 2017

volume

12

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

233-245

1 reference

A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Adverse skin reactions to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Testosterone and anabolic steroids and acne fulminans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

The dire consequences of doping

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

SEVERE ACNE-LIKE LESIONS CAUSED BY AMINEPTINE OVERDOSE

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Severe acne due to chronic amineptine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Acneiform Eruption due to Lithium Carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

A Review and Controlled Study of Cutaneous Conditions associated with Lithium Carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Cutaneous adverse effects of lithium: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Lithium carbonate toxicity. Acneform eruption and other manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Acne keloidalis-like lesions on the scalp associated with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Aripiprazole-induced acneiform eruption

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Adverse cutaneous reactions to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Cyclosporine-induced infantile nodulocystic acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Acne: a potential side effect of cyclosporine A therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Nuchal acne keloidalis associated with cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Facial acne during topical pimecrolimus therapy for vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Adverse cutaneous reactions to antituberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Letter: Acneiform lesions in combined rifampicin treatment in Africans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Drug reactions. 18. Cutaneous reactions to antituberculous drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Letter: Acne and hidden iodides

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Proceedings: Tropical fish tank granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Iododerma after high dose urography in an oliguric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Iododerma occurring after orally administered iopanoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Iododerma: an unusual side effect of iodide ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Use of topical povidone-iodine resulting in an iododerma-like eruption

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Chloracne and chloracnegens

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Chloracne--study of an outbreak with new clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Halothane allergy as cause of acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Severe acneiform eruption exacerbated by dantrolene sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Adverse side-effects to biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Mechanisms of cutaneous toxicities to EGFR inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Histopathologic and Immunohistochemical Characterization of Rash to Human Epidermal Growth Factor Receptor 1 (HER1) and HER1/2 Inhibitors in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Acneiform eruption in a patient receiving bevacizumab for glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588900-000000000-00000

10.2165/11588900-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1002358863

0 references

1 reference